Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Bladder cancer index, Cross-cultural adaptation into Spanish and psychometric evaluation

  • Schmidt, Stefanie
  • Riel, Ricard
  • Frances, Albert
  • Lorente Garín, José Antonio
  • Bonfill, X. (Xavier)|||0000-0003-1530-3509
  • Martinez-Zapata, Mª José|||0000-0002-5836-1138
  • Morales Suárez-Varela, María
  • De la Cruz, Javier|||0000-0002-2010-4128
  • Emparanza, José Ignacio
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Zamora, Javier|||0000-0003-4901-588X
  • Ramos Goñi, Juan Manuel
  • Alonso, Jordi|||0000-0001-8627-9636
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
  • Becerra, Virginia|||0000-0002-8811-3899
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Garin, Olatz|||0000-0001-6193-0779
  • Orrego, Carola|||0000-0002-2978-6268
  • Suñol Sala, Rosa|||0000-0003-1902-833X
  • Osorio, Dimelza|||0000-0001-6166-647X
  • Cánovas, Esther
  • Sancho-Pardo, Gemma|||0000-0003-2266-6172
  • Bolívar, Ignasi
  • Bachs, Jordi
  • Maroto Rey, Pablo|||0000-0002-0030-0412
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • Martín-Lorente, Cristina|||0000-0002-9827-0521
  • Algaba, Ferran|||0000-0002-0071-4164
  • Palou, Juan|||0000-0003-1264-5327
  • Esquena Fernández, Salvador
  • Vernooij, Robin W. M.|||0000-0001-5734-4566
  • Martínez, Arnaia
  • Pijoan Zubizarreta, José Ignacio|||0000-0002-5974-5280
  • Martínez, Lorea G.
  • Castro Díaz, David|||0000-0002-4484-9159
  • López Bastida, Julio|||0000-0002-9354-751X
  • Suárez Pacheco, Armando
  • García López, César
  • Cózar Olmo, José Manuel
  • Martínez García, Carmen
  • Chan, Daisy Chang
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Díaz Moratinos, Ana Isabel
  • Montero, Ángel|||0000-0001-5566-0493
  • Hervás Morón, Asunción|||0000-0002-7439-1820
  • Vallejo Ocaña, Carmen
  • Varona, Constantino
  • Burgos-Revilla, Javier
  • Polo Rubio, Jose Alfredo
  • López-Fando, Luís|||0000-0002-2881-1329
  • Jiménez-Cidre, Miguel Ángel|||0000-0002-9911-8054
  • Muriel García, Alfonso
  • Plana, Maria Nieves|||0000-0003-0921-7954
  • Morera López, Rosa María
  • Sancho García, Sonsoles
  • Abraira, Víctor|||0000-0002-4615-8503
  • Gómez Dos Santos, Victoria
  • Gómez de la Cámara, Agustín
  • Passas Martínez, Juan
  • García Muñoz, Humberto
  • Cabeza Rodríguez, María Ángeles
  • Ruíz Díaz, Irune
  • Sanz-Jaka, Juan Pablo Pedro
  • Velásquez, M. José
  • Llopis González, Agustín|||0000-0001-8701-6918
  • Morales, María
  • Camps, Carlos|||0000-0002-0648-5403
  • Caballero Díaz, Cristina
  • Marqués Vidal, Emilio
  • Sánchez Ballester, Francisco
  • Juan-Escudero, Joaquín Ulises
  • Pastor Peidro, Jorge
  • López-Torrecilla, José Luis
  • Ramos de Campos, Macarena
  • Martorell Cebollada, Miguel
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. Methods: For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debriefing patient interviews. For the assessment of metric properties we used data from 197 bladder cancer patients from a multi-center prospective study. The Spanish BCI and the SF-36 Health Survey were self-administered before and 12 months after treatment. Reliability was estimated by Cronbach's alpha. Construct validity was assessed through the multi-trait multi-method matrix. The magnitude of change was quantified by effect sizes to assess responsiveness. Results: Reliability coefficients ranged 0.75-0.97. The validity analysis confirmed moderate associations between the BCI function and bother subscales for urinary (r = 0.61) and bowel (r = 0.53) domains; conceptual independence among all BCI domains (r ≤ 0.3); and low correlation coefficients with the SF-36 scores, ranging 0.14-0.48. Among patients reporting global improvement at follow-up, pre-post treatment changes were statistically significant for the urinary domain and urinary bother subscale, with effect sizes of 0.38 and 0.53. Conclusions: The Spanish BCI is well accepted, reliable, valid, responsive, and similar in performance compared to the original instrument. These findings support its use, both in Spanish and international studies, as a valuable and comprehensive tool for assessing quality of life across a wide range of bladder cancer patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma, Cross-Sectional Study

  • Hernandez, Gimena|||0000-0001-5319-3465
  • Garin, Olatz|||0000-0001-6193-0779
  • Dima, Alexandra Lelia|||0000-0002-3106-2242
  • Pont, Angels|||0000-0002-0602-552X
  • Martí Pastor, Marc|||0000-0001-6189-2178
  • Alonso, Jordi|||0000-0001-8627-9636
  • Van Ganse, Eric|||0000-0002-7463-9187
  • Laforest, Laurent|||0000-0002-3694-7699
  • de Bruin, Marijn|||0000-0003-3100-6803
  • Mayoral, K.|||0000-0002-7904-4422
  • Serra Sutton, Vicky|||0000-0002-7852-175X
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The EuroQol-5 Dimension (EQ-5D), developed in 1990, is a most widely used generic tool to measure the health-related quality of life (HRQoL) and considered suitable for patients with asthma. In 2009, the EuroQol Group developed a new EQ-5D version to overcome limitations related to its consistently reported high ceiling effect. To enhance the sensitivity for assessing the HRQoL in further patient populations, the number of responses of EQ-5D was increased from 3 to 5 levels (EQ-5D-5L). Moreover, the availability of well-defined requirements for its Web-based administration allows EQ-5D-5L use to monitor the HRQoL in electronic health (eHealth) programs. No study has evaluated the metric properties of the new EQ-5D-5L in patients with asthma yet. This study aims to examine the distribution, construct validity, and reliability of the new EQ-5D-5L questionnaire administered online to adults with asthma. We evaluated patients with asthma (age: 18-40 years) from a primary care setting in France and England, who self-completed the EQ-5D-5L questionnaire online. The inclusion criteria were persistent asthma defined as.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys

  • Martí Pastor, Marc|||0000-0001-6189-2178
  • Pont, Angels|||0000-0002-0602-552X
  • Ávila, Mónica|||0000-0001-9583-5104
  • Garin, Olatz|||0000-0001-6193-0779
  • Vilagut, Gemma|||0000-0002-3714-226X
  • Forero, Carlos G.|||0000-0002-5245-0076
  • Pardo Cladellas, Yolanda|||0000-0003-4982-5495
  • Tresserras, Ricard
  • Medina-Bustos, Antonia
  • Garcia-Codina, Oriol
  • Cabasés, Juan
  • Rajmil, Luis|||0000-0002-6625-0649
  • Alonso, Jordi|||0000-0001-8627-9636
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has improved its distribution, discriminatory power, and validity in the general population. A representative sample (N = 7554) from the Catalan Health Interview Survey 2011-2012, aged ≥18, answered both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within groups of specific chronic conditions and their VAS mean. A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ-5D-3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state within each specific chronic condition was very similar, regardless of the EQ-5D version (≤ 30% in half of the 28 chronic conditions). Although the proportion of individuals with the best possible health state is still very high, our findings support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this new version to measure health in general population, as in the national health surveys. The online version of this article (10.1186/s12963-018-0170-8) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of asthma on women and men, Comparison with the general population using the EQ-5D-5L questionnaire

  • Hernandez, Gimena|||0000-0001-5319-3465
  • Dima, Alexandra Lelia|||0000-0002-3106-2242
  • Pont, Angels|||0000-0002-0602-552X
  • Martí Pastor, Marc|||0000-0001-6189-2178
  • Alonso, Jordi|||0000-0001-8627-9636
  • Van Ganse, Eric|||0000-0002-7463-9187
  • Laforest, Laurent|||0000-0002-3694-7699
  • de Bruin, Marijn|||0000-0003-3100-6803
  • Mayoral, K.|||0000-0002-7904-4422
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
The aim was to evaluate the impact of asthma on patients' Health-Related Quality of Life (HRQoL) by comparing asthmatic women and men with reference norms, to examine the factors which contributed to an impaired HRQoL, and to identify groups at higher risk. Cross-sectional evaluation of 222 primary care patients with persistent asthma (18-40 years old). HRQoL impact was estimated with the EuroQol-5 Dimensions (EQ-5D), which allows calculating Quality-Adjusted Life-Years (QALYs) by applying society preferences. Participants self-completed the EQ-5D questionnaire online. Telephonic interviews collected information on medication and adherence, and administered the Asthma Control Questionnaire. Severity markers included asthma-related comorbidity, previous oral corticosteroids course prescription, and inhaled corticosteroids daily dose. After bivariate analyses, multiple linear regression models were constructed to examine the relations between HRQoL asthma impact and socio-demographic and clinical variables, using as dependent variable the deviation from general population-based EQ-5D reference norms. Deviation from the EQ-5D index norms was moderate in most age/gender groups (-0.1, which corresponds to 0.6 standard deviations), while it was large in women aged 18-24 years (-0.18, corresponding to 1.1 standard deviations). In regression models, a poor asthma control was the only factor independently associated to HRQoL impact in both women and men: β -0.18 (p<0.001) and -0.15 (p = 0.01) respectively. Translating these β coefficients to QALYs, they are interpretable as 66 fewer days of full health per year in women with uncontrolled asthma and 55 for men, compared with those with controlled asthma. Persistent asthma has a moderately negative HRQoL impact on patients of both genders, and the youngest women have been identified as a high risk group which merits further research. We identified asthma control as the major contributor to impaired HRQoL in patients, regardless of their gender, suggesting that asthma HRQoL impact could be alleviated by achieving a good control of symptoms.